These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3988338)

  • 1. Purification and characterization of neurotoxin produced by Clostridium botulinum type C 6813.
    Terajima J; Syuto B; Ochanda JO; Kubo S
    Infect Immun; 1985 May; 48(2):312-7. PubMed ID: 3988338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Clostridium botulinum toxins type D and C1 in molecular property, antigenicity and binding ability to rat-brain synaptosomes.
    Murayama S; Syuto B; Oguma K; Iida H; Kubo S
    Eur J Biochem; 1984 Aug; 142(3):487-92. PubMed ID: 6468375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diversity of neurotoxins from Clostridium botulinum type D strains.
    Moriishi K; Syuto B; Kubo S; Oguma K
    Infect Immun; 1989 Sep; 57(9):2886-91. PubMed ID: 2668193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antigenicity of toxins produced by Clostridium botulinum type C and D strains.
    Ochanda JO; Syuto B; Oguma K; Iida H; Kubo S
    Appl Environ Microbiol; 1984 Jun; 47(6):1319-22. PubMed ID: 6204594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Iida H; Kubo S
    Infect Immun; 1980 Dec; 30(3):656-60. PubMed ID: 6785231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation, purification, partial characterization and comparison of the heavy and light chains of botulinum neurotoxin types A, B, and E.
    Sathyamoorthy V; DasGupta BR
    J Biol Chem; 1985 Sep; 260(19):10461-6. PubMed ID: 4030755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of
    Bano L; Tonon E; Drigo I; Pirazzini M; Guolo A; Farina G; Agnoletti F; Montecucco C
    Toxins (Basel); 2018 Jun; 10(6):. PubMed ID: 29921757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and molecular size of Clostridium botulinum type C toxin.
    Syuto B; Kubo S
    Appl Environ Microbiol; 1977 Feb; 33(2):400-5. PubMed ID: 403861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation and characterization of heavy and light chains from Clostridium botulinum type C toxin and their reconstitution.
    Syuto B; Kubo S
    J Biol Chem; 1981 Apr; 256(8):3712-7. PubMed ID: 6783645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequencing and phylogenetic analysis of neurotoxin gene from an environmental isolate of Clostridium sp.: comparison with other clostridial neurotoxins.
    Dixit A; Alam SI; Singh L
    Arch Toxicol; 2006 Jul; 80(7):399-404. PubMed ID: 16474961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological characterization of Clostridium butyricum neurotoxin and its trypsin-induced fragment by use of monoclonal antibodies against Clostridium botulinum type E neurotoxin.
    Kozaki S; Onimaru J; Kamata Y; Sakaguchi G
    Infect Immun; 1991 Jan; 59(1):457-9. PubMed ID: 1987060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immuno-crossreactivity between botulinum neurotoxin type C1 or D and exoenzyme C3.
    Toratani S; Yokosawa N; Yokosawa H; Ishii S; Oguma K
    FEBS Lett; 1989 Jul; 252(1-2):83-7. PubMed ID: 2474453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an immunodetection test for a botulinum-like neurotoxin produced by Clostridium sp. RKD.
    Dixit A; Alam SI; Dhaked RK; Singh L
    Indian J Med Res; 2006 Sep; 124(3):355-62. PubMed ID: 17085839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the neurotoxin isolated from a Clostridium baratii strain implicated in infant botulism.
    Giménez JA; Giménez MA; DasGupta BR
    Infect Immun; 1992 Feb; 60(2):518-22. PubMed ID: 1730484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and amino acid composition of type A botulinum neurotoxin.
    DasGupta BR; Sathyamoorthy V
    Toxicon; 1984; 22(3):415-24. PubMed ID: 6382680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular composition of progenitor toxin produced by Clostridium botulinum type C strain 6813.
    Watanabe T; Sagane Y; Kouguchi H; Sunagawa H; Inoue K; Fujinaga Y; Oguma K; Ohyama T
    J Protein Chem; 1999 Oct; 18(7):753-60. PubMed ID: 10691185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.
    Miyazaki S; Iwasaki M; Sakaguchi G
    Infect Immun; 1977 Aug; 17(2):395-401. PubMed ID: 892912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial amino acid sequence of the heavy and light chains of botulinum neurotoxin type A.
    Schmidt JJ; Sathyamoorthy V; DasGupta BR
    Biochem Biophys Res Commun; 1984 Mar; 119(3):900-4. PubMed ID: 6370252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and properties of Clostridium botulinum type F toxin.
    Yang KH; Sugiyama H
    Appl Microbiol; 1975 May; 29(5):598-603. PubMed ID: 807160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comparable to the mouse bioassay.
    Shone C; Wilton-Smith P; Appleton N; Hambleton P; Modi N; Gatley S; Melling J
    Appl Environ Microbiol; 1985 Jul; 50(1):63-7. PubMed ID: 3927840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.